These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 35711437)

  • 41. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
    Liu J; Yu F; Liu Z; Wang X; Li J
    Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
    [No Abstract]   [Full Text] [Related]  

  • 42. Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy.
    Wang H; Li Z; Tao Y; Ou S; Ye J; Ran S; Luo K; Guan Z; Xiang J; Yan G; Wang Y; Ma T; Yu S; Song Y; Huang R
    J Transl Med; 2023 Oct; 21(1):713. PubMed ID: 37821882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
    Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
    Front Immunol; 2021; 12():719628. PubMed ID: 34413861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction of a New Tumor Immunity-Related Signature to Assess and Classify the Prognostic Risk of Colorectal Cancer.
    Wu X; Yang T; Qian L; Zhang D; Yang H
    Int J Gen Med; 2021; 14():6661-6676. PubMed ID: 34675628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment.
    Luo Q; Zhou P; Chang S; Huang Z; Zeng X
    Sci Rep; 2023 Mar; 13(1):5106. PubMed ID: 36991138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A robust immune-related lncRNA signature for the prognosis of human colorectal cancer.
    Zhu G; Pei L; Yang F; Zhang C
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35506372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
    Tang Z; Wu Y; Sun D; Xue X; Qin L
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemokine‑ and chemokine receptor-based subtypes predict prognosis, immunotherapy and chemotherapy response in colorectal cancer patients.
    Zhu W; Zhao S; Cheng X; Wu C; Liu Z; Huang J
    Int Immunopharmacol; 2024 Jun; 134():112172. PubMed ID: 38703566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma.
    Yang C; Huang S; Cao F; Zheng Y
    BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternative polyadenylation associated with prognosis and therapy in colorectal cancer.
    Zhang Y; Xu Y; Wang Y
    Sci Rep; 2022 Apr; 12(1):7036. PubMed ID: 35487956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel anoikis-related risk model predicts prognosis in patients with colorectal cancer and responses to different immunotherapy strategies.
    Yang L; Xu F
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10879-10892. PubMed ID: 37318595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer.
    Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T
    Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer.
    Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W
    Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer.
    Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L
    Front Genet; 2023; 14():1186862. PubMed ID: 37323657
    [No Abstract]   [Full Text] [Related]  

  • 57. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
    Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
    Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
    Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
    Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
    Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
    Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer.
    Xiao Y; Zhang G; Wang L; Liang M
    Front Endocrinol (Lausanne); 2022; 13():1069528. PubMed ID: 36518242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.